Literature DB >> 34149046

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.

Dinah Parums1.   

Abstract

The global pandemic of coronavirus disease 2019 (COVID-19) has identified thousands of genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 31st May 2021, the Virus Evolution Working Group of the World Health Organization (WHO) announced its recommendations for revised naming of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs). This new nomenclature system may improve infection monitoring, infection control, and sharing of research data on viral genomics and epidemiology. This Editorial aims to present an update on the current revised WHO terminology for the genomic VOCs and VOIs of SARS-CoV-2.

Entities:  

Mesh:

Year:  2021        PMID: 34149046     DOI: 10.12659/MSM.933622

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  24 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

2.  Two Years of Evolutionary Dynamics of SARS-CoV-2 in Mexico, With Emphasis on the Variants of Concern.

Authors:  Alejandro Flores-Alanis; Gabriela Delgado; Luis F Espinosa-Camacho; Flor Rodríguez-Gómez; Armando Cruz-Rangel; Luisa Sandner-Miranda; Alejandro Cravioto; Rosario Morales-Espinosa
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

3.  Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.

Authors:  Ferran Tarrés-Freixas; Benjamin Trinité; Anna Pons-Grífols; Miguel Romero-Durana; Eva Riveira-Muñoz; Carlos Ávila-Nieto; Mónica Pérez; Edurne Garcia-Vidal; Daniel Perez-Zsolt; Jordana Muñoz-Basagoiti; Dàlia Raïch-Regué; Nuria Izquierdo-Useros; Cristina Andrés; Andrés Antón; Tomàs Pumarola; Ignacio Blanco; Marc Noguera-Julián; Victor Guallar; Rosalba Lepore; Alfonso Valencia; Victor Urrea; Júlia Vergara-Alert; Bonaventura Clotet; Ester Ballana; Jorge Carrillo; Joaquim Segalés; Julià Blanco
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

4.  Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance.

Authors:  Xiaoqing Xu; Yu Deng; Jiahui Ding; Xiawan Zheng; Shuxian Li; Lei Liu; Ho-Kwong Chui; Leo L M Poon; Tong Zhang
Journal:  Water Res       Date:  2022-05-29       Impact factor: 13.400

5.  Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.

Authors:  Tirthankar Koley; Arunima Goswami; Manoj Kumar; Neelam Upadhyay; Gururao Hariprasad
Journal:  Adv Appl Bioinform Chem       Date:  2022-06-16

Review 6.  Omicron - The new SARS-CoV-2 challenge?

Authors:  A Lino; M A Cardoso; P Martins-Lopes; H M R Gonçalves
Journal:  Rev Med Virol       Date:  2022-04-21       Impact factor: 11.043

7.  Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients.

Authors:  Dinah V Parums
Journal:  Med Sci Monit       Date:  2022-01-01

8.  Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus.

Authors:  Tirthankar Koley; Manoj Kumar; Arunima Goswami; Abdul S Ethayathulla; Gururao Hariprasad
Journal:  Biochem Biophys Res Commun       Date:  2022-01-07       Impact factor: 3.322

9.  Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India).

Authors:  Nitin Khandelwal; Yogesh Chander; Ram Kumar; Himanshu Nagori; Assim Verma; Priyasi Mittal; Riyesh T; Sameer Kamboj; Sukhbir Singh Verma; Subhash Khatreja; Yash Pal; Baldev R Gulati; Bhupendra N Tripathi; Sanjay Barua; Naveen Kumar
Journal:  Front Cell Infect Microbiol       Date:  2021-11-23       Impact factor: 5.293

10.  Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.

Authors:  Dinah V Parums
Journal:  Med Sci Monit       Date:  2022-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.